Skip to main content
Tech.euFundingExplorerBeta

Synapse Medicine

Synapse Medicine provides the most advanced AI solutions for #Healthcare and drugs prescriptions.

Synapse Medicine has raised €35M across 3 funding rounds from 5 investors, most recently a Series B round in Mar 2022. Based in Bordeaux, France; founded 2017; active in Healthtech. Data as of 28 Oct 2026.

Bordeaux, FranceFounded 2017synapse-medicine.com ↗
Total raised
€35M
€34,627,584
Funding rounds
3
Investors
5
distinct backers
Active since
2019-01
latest 2022-03

Funding by year

EUR raised per year
Synapse Medicine — funding by year — interactive chart.
Data table
Synapse Medicine — funding by year
2018€2.5M
2020€7.1M
2022€25M

Signals

High confidence
Raise-next likelihood10
base rate 48% for Series B
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood11
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▲ 9y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2022-03-01Series B€25MBNP Paribas Development,Fleur Pellerin investment fund,Korelya Capital,MACSF,XAngeView deal →
2020-07-06Other€7.1MMACSFView deal →
2019-01-01Seed€2.5MXAngeView deal →

Similar companies

same sector or country

Global coverage: FundingData